Latest & greatest articles for cetirizine

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on cetirizine or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on cetirizine and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for cetirizine

1. Cetirizine

Cetirizine Top results for cetirizine - Trip Database or use your Google+ account Liberating the literature ALL of these words: Title only Anywhere in the document ANY of these words: Title only Anywhere in the document This EXACT phrase: Title only Anywhere in the document EXCLUDING words: Title only Anywhere in the document Timeframe: to: Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 (...) or #4) Loading history... Population: Intervention: Comparison: Outcome: Population: Intervention: Latest & greatest articles for cetirizine The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence

2018 Trip Latest and Greatest

2. Comparative Effect of Beclomethasone Dipropionate and Cetirizine on Acoustic Rhinometry Parameters in Children With Perennial Allergic Rhinitis: A Randomized Controlled Trial. (PubMed)

Comparative Effect of Beclomethasone Dipropionate and Cetirizine on Acoustic Rhinometry Parameters in Children With Perennial Allergic Rhinitis: A Randomized Controlled Trial. The effect of intranasal corticosteroids and oral antihistamines on acoustic rhinometry parameters has not been directly compared. The primary objective was to compare the effect of a 21-day course of treatment with nasal beclomethasone dipropionate (nBDP) with that of cetirizine (CTZ) on nasal patency measured using

Full Text available with Trip Pro

2018 Journal of investigational allergology & clinical immunology

3. Chronic urticaria: off-label doses of cetirizine

Chronic urticaria: off-label doses of cetirizine Chronic urticaria: off-label doses of cetirizine Chronic urticaria: off-label doses of cetirizine Evidence summary Published: 8 July 2014 nice.org.uk/guidance/esuom31 pathways K Ke ey points from the e y points from the evidence vidence The content of this evidence summary was up-to-date in July 2014. See summaries of product characteristics (SPCs), British national formulary (BNF) or the MHRA or NICE websites for up- to-date information. Summary (...) Overall, 2 small randomised controlled trials (RCTs) and 2 double-blind crossover studies (total n=76) suggest that cetirizine 20 mg daily may improve weals and itching in adults with severe chronic urticaria refractory to standard doses of antihistamines. However, symptoms remain in a proportion of people and the studies have many limitations. Nevertheless, cetirizine 20 mg appears to be well tolerated and the benefits may outweigh the risks for some people whose quality of life is significantly

2014 National Institute for Health and Clinical Excellence - Advice

4. Cetirizine

Cetirizine USE OF CETIRIZINE IN PREGNANCY 0344 892 0909 USE OF CETIRIZINE IN PREGNANCY (Date of issue: November 2018 , Version: 3 ) This is a UKTIS monograph for use by health care professionals. For case-specific advice please contact UKTIS on 0344 892 0909. To report an exposure please download and complete a . Please encourage all women to complete an . A corresponding patient information leaflet on is available at . Summary Cetirizine, the active metabolite of hydroxyzine, is a non-sedating (...) antihistamine used for the symptomatic relief of allergic conditions including rhinitis (hay fever) and chronic idiopathic urticaria. Studies which have investigated maternal cetirizine use in pregnancy do not provide evidence of an increased risk of congenital malformation, intrauterine growth restriction or preterm delivery. Whilst the majority of controlled studies investigating spontaneous abortion risks following maternal cetirizine use in pregnancy provide no evidence of an association, a single study

2014 UK Teratology Information Service

5. Zyrtec Allergy (cetirizine HCl) orally disintegrating tablets

Zyrtec Allergy (cetirizine HCl) orally disintegrating tablets Drug Approval Package: Zyrtec Allergy (cetirizine) NDA #022578 Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - Zyrtec Allergy (cetirizine HCl) orally disintegrating tablets, 10 mg Company: McNeil Consumer Healthcare Application No.: 022578 Approval Date: 09/03/2010 Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance. (PDF) (PDF) (PDF

2011 FDA - Drug Approval Package

6. Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. (PubMed)

Randomised controlled trial of butterbur and cetirizine for treating seasonal allergic rhinitis. To compare the efficacy and tolerability of butterbur (Petasites hybridus) with cetirizine in patients with seasonal allergic rhinitis (hay fever).Randomised, double blind, parallel group comparison.Four outpatient general medicine and allergy clinics in Switzerland and Germany.131 patients were screened for seasonal allergic rhinitis and 125 patients were randomised (butterbur 61; cetirizine 64 (...) ).Butterbur (carbon dioxide extract tablets, ZE 339) one tablet, four times daily, or cetirizine, one tablet in the evening, both given for two consecutive weeks.Scores on SF-36 questionnaire and clinical global impression scale.Improvement in SF-36 score was similar in the two treatment groups for all items tested hierarchically. Butterbur and cetirizine were also similarly effective with regard to global improvement scores on the clinical global impression scale (median score 3 in both groups). Both

Full Text available with Trip Pro

2002 BMJ